SCHEMBL20101034

SCHEMBL20101034

c1ccc(/C(=N\Nc2nc(-c3ccccc3)cs2)c2ccccn2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.72
MAOB P27338 5/20 0.72
ALDH1A1 P00352 3/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
HIF1A Q16665 1/20 0.63
HSP90AA1 P07900 1/20 0.63
MEN1 O00255 6/20 0.60
KMT2A Q03164 6/20 0.60
GAA P10253 3/20 0.60
ALOX12 P18054 2/20 0.60
LMNA P02545 2/20 0.60
GFER P55789 1/20 0.60
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
HPGD P15428 1/20 0.53
MAPT P10636 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28366328 1.00 MAOA (0.72) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28720595 0.92 MAOA (0.61) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28720593 0.92 MAOA (0.61) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28719673 0.89 MAOA (0.61) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28362720 0.89 MAOA (0.58) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28362719 0.89 MAOA (0.58) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28719677 0.89 MAOA (0.61) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28362601 0.84 MAOA (0.63) MAOAMAOBALDH1A1CYP1A2CYP3A4
SCHEMBL28362727 0.84 MAOA (0.63) MAOAMAOBMEN1KMT2AGAA
SCHEMBL28723609 0.84 MAOA (0.63) MAOAMAOBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110713487-B Novel heterocyclic aromatic hydrazone derivative, pharmaceutically acceptable salt thereof, preparation method and application thereof 南京大学 2022-02-15 CN disclosed
CN-110713487-A Novel heterocyclic aromatic hydrazone derivative, pharmaceutically acceptable salt thereof, preparation method and application thereof 南京大学 2020-01-21 CN disclosed
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed